PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 643.00
+3.00 (0.47%)
At close: Mar 26, 2026
PharmaEssentia Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5,045 | 2,966 | -623.84 | -1,375 | -2,811 |
Depreciation & Amortization | 351.55 | 336.99 | 250.58 | 225.38 | 226 |
Other Amortization | 47.05 | 30.72 | 18.18 | 2.54 | 1.09 |
Loss (Gain) From Sale of Assets | 2.03 | 0.93 | - | 0.1 | 0.07 |
Loss (Gain) on Equity Investments | 4.46 | - | - | - | - |
Stock-Based Compensation | 463.47 | 164.39 | 710.21 | 216.21 | 501.52 |
Other Operating Activities | -302.77 | -275.6 | -383.62 | -464.93 | 11.18 |
Change in Accounts Receivable | -1,849 | -1,312 | -513.66 | -332.6 | -15.45 |
Change in Inventory | -62.21 | 25.34 | -356.61 | -240.66 | -466.53 |
Change in Accounts Payable | 30.27 | -2.44 | -102.05 | 54.62 | -0.69 |
Change in Unearned Revenue | -0.23 | 0.23 | - | - | - |
Change in Other Net Operating Assets | 1,547 | 590.17 | 291.29 | 408.68 | 91.74 |
Operating Cash Flow | 5,278 | 2,525 | -709.51 | -1,505 | -2,462 |
Operating Cash Flow Growth | 109.04% | - | - | - | - |
Capital Expenditures | -1,911 | -862 | -1,286 | -312.03 | -70.33 |
Sale (Purchase) of Intangibles | -12.51 | -41.49 | -41.65 | -8.72 | -27.54 |
Investment in Securities | -440.1 | -423.65 | -96 | - | -25 |
Other Investing Activities | -111.32 | -7.76 | 937.04 | -922.07 | 44.7 |
Investing Cash Flow | -2,475 | -1,335 | -486.65 | -1,243 | -78.18 |
Short-Term Debt Issued | 2,243 | - | 1 | 973.88 | - |
Total Debt Issued | 2,243 | - | 1 | 973.88 | - |
Short-Term Debt Repaid | -2,243 | -21 | -973.88 | - | -30 |
Long-Term Debt Repaid | -229.31 | -233.12 | -150.97 | -127.41 | -116.23 |
Total Debt Repaid | -2,472 | -254.12 | -1,125 | -127.41 | -146.23 |
Net Debt Issued (Repaid) | -229.31 | -254.12 | -1,124 | 846.47 | -146.23 |
Issuance of Common Stock | 95.55 | 91.1 | 14,330 | 8,743 | 3,045 |
Repurchase of Common Stock | - | - | -2,718 | - | -87.5 |
Common Dividends Paid | -366.17 | - | - | - | - |
Other Financing Activities | - | - | -34.56 | -10.26 | -2.41 |
Financing Cash Flow | -499.93 | -163.02 | 10,454 | 9,579 | 2,809 |
Foreign Exchange Rate Adjustments | -660.75 | 358.27 | 104.11 | 19 | -15.25 |
Net Cash Flow | 1,642 | 1,385 | 9,362 | 6,850 | 253.27 |
Free Cash Flow | 3,366 | 1,663 | -1,996 | -1,818 | -2,532 |
Free Cash Flow Growth | 102.47% | - | - | - | - |
Free Cash Flow Margin | 21.53% | 17.08% | -39.09% | -63.06% | -385.74% |
Free Cash Flow Per Share | 9.07 | 4.49 | -5.58 | -5.76 | -8.77 |
Cash Interest Paid | 25.53 | 22.19 | 34.56 | 10.26 | 2.41 |
Cash Income Tax Paid | 232.89 | 297.9 | 76.87 | 5.68 | -0 |
Levered Free Cash Flow | 2,126 | 21.42 | -1,292 | -2,589 | -1,316 |
Unlevered Free Cash Flow | 2,142 | 35.29 | -1,263 | -2,577 | -1,310 |
Change in Working Capital | -333.28 | -698.22 | -681.02 | -109.97 | -390.93 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.